Amicus Therapeutics Announces Presentation and Posters at the 2021 MDA Clinical & Scientific Conference
PHILADELPHIA, March 15, 2021 (GLOBE NEWSWIRE) -- Amicus Therapeutics (Nasdaq: FOLD), today announced one oral presentation and two posters highlighting its development program for Pompe disease will be included at the 2021 MDA Virtual Clinical & Scientific Conference to be held March 15-18, 2021.
Oral Platform Presentation: Thursday, March 18, 5:30 – 5:45 p.m. ET
The posters and presentation will be made available on the Amicus website following their respective presentations at the conference.
For more information on the 2021 MDA Virtual Clinical & Scientific Conference, please visit www.mdaconference.org.
In addition, Amicus is enrolling an open-label, uncontrolled, multicenter study to evaluate the PK, safety, efficacy, and PD of AT-GAA in pediatric patients aged 12 to <18 years with LOPD (ATB200-04). More information, including a list of participating sites, is available at www.clinicaltrials.gov: NCT03911505
About Pompe Disease
About Amicus Therapeutics
VoIP & RTC Monitoring: Doing Less with More!
Session Details Coming Soon